In the current issue:
-
Clinical presentations of the most common histiocytic disorders
Adam Zdeněk et al. -
Second and subsequent lines of systemic therapy in endometrial cancer – a real-life clinical experience
Bednaříková Markéta et al. -
From progression to complete remission – a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma
Bohuňovská Kateřina
Reviews
Klin Onkol 2026; 39(3): 150-168.
DOI: 10.48095/ccko2026150.
Keywords: histiocytosis
Authors: Adam Zdeněk, Eid Michal, Řehák Zdeněk, Kubeš Václav , Horváth Teodor, Doubková Martina, Starý Karel, Šlampa Pavel, Čermák Aleš, Fadrus Pavel, Adamová Zuzana, Vaníček Jiří, Nebeský Tomáš, Kamarádová Kateřina, Boichuk Ivanna, Pour Luděk2026-06-15:Clinical presentations of the most common histiocytic disorders
Keywords: histiocytosis
Authors: Adam Zdeněk, Eid Michal, Řehák Zdeněk, Kubeš Václav , Horváth Teodor, Doubková Martina, Starý Karel, Šlampa Pavel, Čermák Aleš, Fadrus Pavel, Adamová Zuzana, Vaníček Jiří, Nebeský Tomáš, Kamarádová Kateřina, Boichuk Ivanna, Pour Luděk2026-06-15:Clinical presentations of the most common histiocytic disorders
Klin Onkol 2026; 39(3): 169-183.
DOI: 10.48095/ccko2026169.
Keywords: Castleman disease
Authors: Adam Zdeněk, Kamarádová Kateřina, Doubková Martina, Řehák Zdeněk, Koukalová Renata, Křivanová Andrea, Horváth Teodor, Čermák Aleš, Boichuk Ivanna, Štork Martin, Sandecká Viera, Adamová Zuzana, Pour Luděk2026-06-15:Chronic low-grade fever or fever with mild lymphadenopathy may indicate Castleman disease if no malignant, autoimmune, or infectious cause of the lymphadenopathy is identified
Keywords: Castleman disease
Authors: Adam Zdeněk, Kamarádová Kateřina, Doubková Martina, Řehák Zdeněk, Koukalová Renata, Křivanová Andrea, Horváth Teodor, Čermák Aleš, Boichuk Ivanna, Štork Martin, Sandecká Viera, Adamová Zuzana, Pour Luděk2026-06-15:Chronic low-grade fever or fever with mild lymphadenopathy may indicate Castleman disease if no malignant, autoimmune, or infectious cause of the lymphadenopathy is identified
Original articles
Klin Onkol 2026; 39(3): 184-194.
DOI: 10.48095/ccko2026184.
Keywords: endometrial cancer – systemic treatment – chemotherapy – immunotherapy – second and subsequent lines of therapy – pembrolizumab – lenvatinib
Authors: Bednaříková Markéta, Koblížková Michaela, Ovesná Petra, Hausnerová Jitka, Ehrlichová Lucie, Felsinger Michal , Tomková Martina, Minář Luboš, Weinberger Vít2026-06-15:Second and subsequent lines of systemic therapy in endometrial cancer – a real-life clinical experience
Keywords: endometrial cancer – systemic treatment – chemotherapy – immunotherapy – second and subsequent lines of therapy – pembrolizumab – lenvatinib
Authors: Bednaříková Markéta, Koblížková Michaela, Ovesná Petra, Hausnerová Jitka, Ehrlichová Lucie, Felsinger Michal , Tomková Martina, Minář Luboš, Weinberger Vít2026-06-15:Second and subsequent lines of systemic therapy in endometrial cancer – a real-life clinical experience
Case report
Klin Onkol 2026; 39(3): 195-198.
DOI: 10.48095/ccko2026195.
Keywords: cholangiocarcinoma – targeted therapy – pemigatinib – FGFR tyrosine kinase inhibitor
Authors: Bohuňovská Kateřina2026-06-15:From progression to complete remission – a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma
Keywords: cholangiocarcinoma – targeted therapy – pemigatinib – FGFR tyrosine kinase inhibitor
Authors: Bohuňovská Kateřina2026-06-15:From progression to complete remission – a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma
Klin Onkol 2026; 39(3): 199-211.
DOI: 10.48095/ccko2026199.
Keywords: Erdheim-Chester disease – FDG-PET/CT – NaF-PET/CT – skeletal scintigraphy – anakinra – cladribine
Authors: Řehák Zdeněk, Stejskal Václav, Adam Zdeněk, Kamarádová Kateřina, Štěpánková Pavla, Soboličová Sandra, Ošmera Pavel, Starý Karel, Nehyba Svatopluk, Čermák Aleš, Standara Michal, Pour Luděk2026-06-15:Differences in the imaging of Erdheim-Chester disease using FDG-PET/CT, NaF-PET/CT examinations, and skeletal scintigraphy. Regression of the disease after treatment with cladribine combined with cyclophosphamide and anakinra
Keywords: Erdheim-Chester disease – FDG-PET/CT – NaF-PET/CT – skeletal scintigraphy – anakinra – cladribine
Authors: Řehák Zdeněk, Stejskal Václav, Adam Zdeněk, Kamarádová Kateřina, Štěpánková Pavla, Soboličová Sandra, Ošmera Pavel, Starý Karel, Nehyba Svatopluk, Čermák Aleš, Standara Michal, Pour Luděk2026-06-15:Differences in the imaging of Erdheim-Chester disease using FDG-PET/CT, NaF-PET/CT examinations, and skeletal scintigraphy. Regression of the disease after treatment with cladribine combined with cyclophosphamide and anakinra
Onkology in pictures
Klin Onkol 2026; 39(3): 212-214.
Authors: Bencsiková Beatrix, Hendrych Michal, Řehák Zdeněk, Jančálek Radim, Brychta Jindřich, Balážová Zuzana2026-06-15:68Ga-DOTATOC PET/CT – a case report of synchronous oncological duplicity with high expression of somatostatin receptors
Authors: Bencsiková Beatrix, Hendrych Michal, Řehák Zdeněk, Jančálek Radim, Brychta Jindřich, Balážová Zuzana2026-06-15:68Ga-DOTATOC PET/CT – a case report of synchronous oncological duplicity with high expression of somatostatin receptors